ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
61 838,38
1,56%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. TC BioPharm Holdings PLC (TCBP)

  7. TC BioPharm Holdings PLC (TCBP) Actualités

TCBP

TC BioPharm (TCBP)

TC BioPharm Holdings PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TCBP
DateHeureSourceTitreSymboleSociété
15/05/202414h30PR Newswire (US)TCBP Announces Launch of Compassionate Use Program for TCB008NASDAQ:TCBPTC BioPharm Holdings PLC
06/05/202419h01PR Newswire (US)TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross ProceedsNASDAQ:TCBPTC BioPharm Holdings PLC
06/05/202414h30PR Newswire (US)TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T TherapiesNASDAQ:TCBPTC BioPharm Holdings PLC
04/04/202414h32PR Newswire (US)TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform TechnologiesNASDAQ:TCBPTC BioPharm Holdings PLC
02/04/202414h30PR Newswire (US)TCBP Increasing Treatment Capacity with Expanded Manufacturing ProcessNASDAQ:TCBPTC BioPharm Holdings PLC
19/03/202413h30PR Newswire (US)TCBP Adjourns General Meeting Until a Later DateNASDAQ:TCBPTC BioPharm Holdings PLC
18/03/202413h30PR Newswire (US)TCBP Announces Exercise of Series D Warrants For CashNASDAQ:TCBPTC BioPharm Holdings PLC
06/03/202412h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCBPTC BioPharm Holdings PLC
01/03/202414h30PR Newswire (US)Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show"NASDAQ:TCBPTC BioPharm Holdings PLC
27/02/202423h15PR Newswire (US)/C O R R E C T I O N -- TC BioPharm/NASDAQ:TCBPTC BioPharm Holdings PLC
27/02/202414h30PR Newswire (US)TCBP Announces Shareholder Update Call on March 5th 2024NASDAQ:TCBPTC BioPharm Holdings PLC
22/02/202415h32PR Newswire (US)TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK TrialNASDAQ:TCBPTC BioPharm Holdings PLC
20/02/202412h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TCBPTC BioPharm Holdings PLC
15/02/202414h30PR Newswire (US)TC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit EuropeNASDAQ:TCBPTC BioPharm Holdings PLC
14/02/202414h30PR Newswire (US)TCBP Provides Shareholder Update and Highlights Upcoming MilestonesNASDAQ:TCBPTC BioPharm Holdings PLC
09/02/202421h26Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TCBPTC BioPharm Holdings PLC
29/01/202415h16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCBPTC BioPharm Holdings PLC
29/01/202414h30PR Newswire (US)TC BioPharm Chief Executive Officer, Bryan Kobel Featured on 'The Big Biz Show'NASDAQ:TCBPTC BioPharm Holdings PLC
18/01/202414h30PR Newswire (US)TC BioPharm to Present at the Sequire Investor SummitNASDAQ:TCBPTC BioPharm Holdings PLC
04/01/202414h30PR Newswire (US)TC BioPharm Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:TCBPTC BioPharm Holdings PLC
03/01/202414h30PR Newswire (US)TC BioPharm Announces Additional Cost Reduction Steps to Improve Financial Standing and Streamline EfficienciesNASDAQ:TCBPTC BioPharm Holdings PLC
22/12/202314h30PR Newswire (US)TC BioPharm Announces Closing of $3.5 Million Public OfferingNASDAQ:TCBPTC BioPharm Holdings PLC
21/12/202323h14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TCBPTC BioPharm Holdings PLC
19/12/202314h00PR Newswire (US)TC BioPharm Announces Pricing of $3.5 Million Public OfferingNASDAQ:TCBPTC BioPharm Holdings PLC
19/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TCBPTC BioPharm Holdings PLC
18/12/202317h15PR Newswire (US)TC BioPharm Announces Formation of Commercial Development Division, Led by Industry Veteran, Dr. Lauren Bor Ph.DNASDAQ:TCBPTC BioPharm Holdings PLC
14/12/202323h20Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:TCBPTC BioPharm Holdings PLC
13/12/202312h30PR Newswire (US)TC BioPharm Announces Plan to Implement ADS Ratio ChangeNASDAQ:TCBPTC BioPharm Holdings PLC
27/11/202314h45PR Newswire (US)TC BioPharm Announces FDA Clearance of Phase 1B IND for TCB-008 in Acute Myeloid LeukemiaNASDAQ:TCBPTC BioPharm Holdings PLC
14/11/202316h00PR Newswire (US)TC BioPharm Announces Successful Completion of Safety Cohort and Positive DSMB ResultsNASDAQ:TCBPTC BioPharm Holdings PLC
 Showing the most relevant articles for your search:NASDAQ:TCBP

Dernières Valeurs Consultées

NASDAQ
AMZN
Amazon.com
EU
VK
Vallourec
EU
ACA
Credit Agricole
NYSE
JPM
JP Morgan Chase
EU
BN
Danone
NASDAQ
NVDA
NVIDIA
SPI
SP500
S&P 500
FTSE
UKX
FTSE 100
NYSE
MRK
Merck
EU
VIV
Vivendi
NASDAQ
AAPL
Apple
EU
CS
Axa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés